Implementation of a urogynecology-specific enhanced recovery after surgery (ERAS) pathway
- PMID: 29913175
- PMCID: PMC7212495
- DOI: 10.1016/j.ajog.2018.06.009
Implementation of a urogynecology-specific enhanced recovery after surgery (ERAS) pathway
Abstract
Objective: Enhanced recovery after surgery protocols were developed for colorectal surgery to hasten postoperative recovery. Variations of the protocol are being adopted for gynecological procedures despite limited population and procedure-specific outcome data. Our objective was to evaluate whether implementation of an enhanced recovery after surgery pathway would facilitate reduced length of admission in a urogynecology population.
Materials and methods: In this retrospective analysis of patients undergoing pelvic floor reconstructive surgery by 7 female pelvic medicine and reconstructive surgeons, we compared same-day discharge, length of admission and postoperative complications before and after implementation of an enhanced recovery after surgery pathway at a tertiary care hospital. Groups were compared using χ2 and Student t tests. Candidate variables that could have an impact on patient outcomes with P < .2 were included in multivariable logistic regression models. Satisfaction with surgical experience was assessed using a phone-administered questionnaire the day after discharge.
Results: Mean age and body mass index of 258 women (137 before enhanced recovery after surgery and 121 enhanced recovery after surgery) were 65.5 ± 11.3 years and 28.2 ± 5.0 kg/m2. The most common diagnosis was pelvic organ prolapse (n = 242, 93.8%) including stage III pelvic organ prolapse (n = 61, 65.1%). Apical suspension procedures included 58 transvaginal (25.1%), 112 laparoscopic/robotic (48.8%), and 61 obliterative (26.4%). Hysterectomy was performed in 57.4% of women. Demographic and surgical procedures were similar in both groups. Compared with before enhanced recovery after surgery, the enhanced recovery after surgery group had a higher proportion of same-day discharge (25.9% vs 91.7%, P < .001) and a 13.8 hour shorter duration of stay (25.9 ± 13.5 vs 12.1 ± 11.2 hours, P <.001). Operative and postsurgical recovery room times were similar (2.6 ± 0.8 vs 2.6 ± 0.9 hours, P =.955; 3.7 ± 2.1 vs 3.6 ± 2.2 hours, P = .879). Women in the enhanced recovery after surgery group were more likely to be discharged using a urethral catheter (57.9% enhanced recovery after surgery vs 25.4% before enhanced recovery after surgery, P = .005). There were no group differences in total 30 day postoperative complications overall and for the following categories: urinary tract infections, emergency room visits, unanticipated office visits, and return to the operating room. However, enhanced recovery after surgery patients had higher 30 day hospital readmission rates (n = 8, 6.7% vs n = 2, 1.5%, P = .048). Patients before enhanced recovery after surgery were readmitted for myocardial infarction and chest pain. Enhanced recovery after surgery patients were admitted for weakness, chest pain, hyponatremia, wound complications, nausea/ileus, and ureteral obstruction. Three enhanced recovery after surgery patients returned to the operating room for ureteral obstruction (n = 1), incisional hernia (n = 1), and vaginal cuff bleeding (n = 1). Enhanced recovery after surgery patients also had more postoperative nursing phone notes (2.6 ± 1.7 vs 2.1 ± 1.4, P = .030). On multivariable logistic regressions adjusting for age and operative time, same-day discharge was more likely in the enhanced recovery after surgery group (odds ratio, 32.73, 95% confidence interval [15.23-70.12]), while the odds of postoperative complications and emergency room visits were no different. After adjusting for age, operative time, and type of prolapse surgery, readmission was more likely in the enhanced recovery after surgery group (odds ratio, 32.5, 95% confidence interval [1.1-28.1]). In the enhanced recovery after surgery group, patient satisfaction (n = 77 of 121) was reported as very good or excellent by 86.7% for pain control, 89.6% for surgery preparedness, and 93.5% for overall surgical experience; 89.6% did not recall any postoperative nausea during recovery.
Conclusion: Enhanced recovery after surgery implementation in a urogynecology population resulted in a greater proportion of same-day discharge and high patient satisfaction but with slightly increased hospital readmissions within 30 days.
Keywords: enhanced recover after surgery; pelvic floor reconstructive surgery; pelvic organ prolapse; same-day discharge.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
30-Day unanticipated healthcare encounters after prolapse surgery: impact of same day discharge.Am J Obstet Gynecol. 2020 May;222(5):482.e1-482.e8. doi: 10.1016/j.ajog.2019.11.1249. Epub 2019 Nov 13. Am J Obstet Gynecol. 2020. PMID: 31733206 Free PMC article.
-
Comparison of 30-Day Readmission After Same-Day Compared With Next-Day Discharge in Minimally Invasive Pelvic Organ Prolapse Surgery.Obstet Gynecol. 2020 Jun;135(6):1327-1337. doi: 10.1097/AOG.0000000000003871. Obstet Gynecol. 2020. PMID: 32459424
-
Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.Am J Obstet Gynecol. 2020 Aug;223(2):268.e1-268.e26. doi: 10.1016/j.ajog.2020.05.020. Epub 2020 May 13. Am J Obstet Gynecol. 2020. PMID: 32413430
-
Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines.Am J Obstet Gynecol. 2018 Aug;219(2):129-146.e2. doi: 10.1016/j.ajog.2018.01.018. Epub 2018 Jan 17. Am J Obstet Gynecol. 2018. PMID: 29353031
-
Surgery in urogynecology.Minerva Med. 2012 Feb;103(1):23-36. Minerva Med. 2012. PMID: 22278066 Review.
Cited by
-
Enhanced Recovery: A Decade of Experience and Future Prospects at the Mayo Clinic.Healthcare (Basel). 2021 May 8;9(5):549. doi: 10.3390/healthcare9050549. Healthcare (Basel). 2021. PMID: 34066696 Free PMC article.
-
Pudendal Nerve Block Analgesia at the Time of Vaginal Surgery: A Randomized, Double-Blinded, Sham-Controlled Trial.Urogynecology (Phila). 2023 Oct 1;29(10):827-835. doi: 10.1097/SPV.0000000000001351. Epub 2023 Apr 4. Urogynecology (Phila). 2023. PMID: 37093572 Free PMC article. Clinical Trial.
-
ACERTO PROJECT: IMPACT ON ASSISTANCE OF A PUBLIC EMERGENCY HOSPITAL.Arq Bras Cir Dig. 2021 Jan 15;33(3):e1544. doi: 10.1590/0102-672020200003e1544. eCollection 2021. Arq Bras Cir Dig. 2021. PMID: 33470374 Free PMC article.
-
Clinical pathways for secondary care and the effects on professional practice, patient outcomes, length of stay and hospital costs.Cochrane Database Syst Rev. 2025 May 14;5(5):CD006632. doi: 10.1002/14651858.CD006632.pub3. Cochrane Database Syst Rev. 2025. PMID: 40365866 Review.
-
Mode of anesthesia and major perioperative outcomes associated with vaginal surgery.Int Urogynecol J. 2020 Jan;31(1):181-189. doi: 10.1007/s00192-019-03908-x. Epub 2019 Mar 12. Int Urogynecol J. 2020. PMID: 30863946
References
-
- Kalogera E, Dowdy SC. Enhanced Recovery Pathway in Gynecologic Surgery: Improving Outcomes Through Evidence-Based Medicine. Obstet Gynecol Clin North Am 2016. September;43(3):551–73. - PubMed
-
- Ljungqvist O ERAS--enhanced recovery after surgery: moving evidence-based perioperative care to practice. JPEN J Parenter Enteral Nutr 2014. July;38(5):559–66. - PubMed
-
- Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, et al. Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I. Gynecol Oncol 2016. February;140(2):313–22. - PubMed
-
- Nelson G, Kalogera E, Dowdy SC. Enhanced recovery pathways in gynecologic oncology. Gynecol Oncol 2014. December;135(3):586–94. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical